UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): December 29, 2017

                                 AMERICANN, INC.
                  -------------------------------------------
             (Exact name of registrant as specified in its charter)

        Delaware                      000-54231               27-4336843
-----------------------------    --------------------     ----------------
 (State or other jurisdiction    (Commission File No.)     (IRS Employer
  of incorporation)                                     Identification No.)


                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                      ------------------------------------
          (Address of principal executive offices, including Zip Code)


Registrant's telephone number, including area code:(303) 862-9000


                                       N/A
                          ---------------------------
          (Former name or former address if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
    CFR 240.14a-12(b))

[ ] Pre-commencement  communications  pursuant  to Rule  14d-2(b)  under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))

Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has
elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. [ ]

<PAGE>


Item 1.01   Entry Into a Material Definitive Agreement

     On December 29, 2017 the Company sold  convertible  notes in the  principal
amount of $800,000 to a group of accredited  investors.  The notes bear interest
at 8% per year, are unsecured,  and are due and payable on December 31, 2018. At
the  option of the note  holders,  the notes may be  converted  at any time into
shares of the Company's common stock at an initial conversion price of $1.50 per
share.

     The note holders also received  warrants  which entitle the note holders to
purchase up to 533,333  shares of the Company's  common stock.  The warrants are
exercisable at a price of $1.50 per share and expire on October 17, 2022.

     GVC Capital LLC acted as the placement  agent for the offering and received
a cash  commission of $64,000,  plus warrants to purchase  106,667 shares of the
Company's  common stock.  The warrants are  exercisable  at a price of $1.50 per
share and expire on December 31, 2022.

     The  Company  relied  upon  the  exemption  provided  by  Rule  506  of the
Securities  and Exchange  Commission in connection  with sale of the  securities
described above.  The persons who acquired these  securities were  sophisticated
investors and were provided full  information  regarding the Company's  business
and operations.  There was no general  solicitation in connection with the offer
or sale of these securities.  The persons who acquired these securities acquired
them for their own accounts. The certificates representing these securities will
bear a restricted  legend  providing that they cannot be sold except pursuant to
an effective registration statement or an exemption from registration.

Item 2.03.  Creation of a Direct Financial Obligation or an Obligation Under
            an Off-Balance Sheet Arrangement of a Registrant.

      See Item 1.01 of this report.

Item 3.02   Unregistered Sale of Equity Securities.

      See Item 1.01 of this report.


<PAGE>


                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date: January 4, 2018.
                                AMERICANN, INC.


                                By:/s/ Benjamin J. Barton
                                   -------------------------------
                                   Benjamin J. Barton, Chief Financial Officer
[{"type": "8-K", "sequence": "1", "filename": "form8k101decfin1-18.txt", "description": "8-K RE DEC. FINANCING", "secsgml_size_bytes": 4715}]
{"company-data": {"conformed-name": "AmeriCann, Inc.", "cik": "0001508348", "assigned-sic": "8742", "irs-number": "274336843", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54231", "film-number": "18512706"}, "business-address": {"street1": "3200 BRIGHTON BLVD.", "street2": "UNIT 114", "city": "DENVER", "state": "CO", "zip": "80216", "phone": "303-862-9000"}, "mail-address": {"street1": "3200 BRIGHTON BLVD.", "street2": "UNIT 114", "city": "DENVER", "state": "CO", "zip": "80216"}, "former-company": [{"former-conformed-name": "Americann, Inc.", "date-changed": "20140516"}, {"former-conformed-name": "Nevada Health Scan, Inc.", "date-changed": "20101220"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): December 29, 2017

                                 AMERICANN, INC.
                  -------------------------------------------
             (Exact name of registrant as specified in its charter)

        Delaware                      000-54231               27-4336843
-----------------------------    --------------------     ----------------
 (State or other jurisdiction    (Commission File No.)     (IRS Employer
  of incorporation)                                     Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                      ------------------------------------
          (Address of principal executive offices, including Zip Code)

Registrant's telephone number, including area code:(303) 862-9000

                                       N/A
                          ---------------------------
          (Former name or former address if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
    CFR 240.14a-12(b))

[ ] Pre-commencement  communications  pursuant  to Rule  14d-2(b)  under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))

Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has
elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. [ ]
Item 1.01   Entry Into a Material Definitive Agreement

     On December 29, 2017 the Company sold  convertible  notes in the  principal
amount of $800,000 to a group of accredited  investors.  The notes bear interest
at 8% per year, are unsecured,  and are due and payable on December 31, 2018. At
the  option of the note  holders,  the notes may be  converted  at any time into
shares of the Company's common stock at an initial conversion price of $1.50 per
share.

     The note holders also received  warrants  which entitle the note holders to
purchase up to 533,333  shares of the Company's  common stock.  The warrants are
exercisable at a price of $1.50 per share and expire on October 17, 2022.

     GVC Capital LLC acted as the placement  agent for the offering and received
a cash  commission of $64,000,  plus warrants to purchase  106,667 shares of the
Company's  common stock.  The warrants are  exercisable  at a price of $1.50 per
share and expire on December 31, 2022.

     The  Company  relied  upon  the  exemption  provided  by  Rule  506  of the
Securities  and Exchange  Commission in connection  with sale of the  securities
described above.  The persons who acquired these  securities were  sophisticated
investors and were provided full  information  regarding the Company's  business
and operations.  There was no general  solicitation in connection with the offer
or sale of these securities.  The persons who acquired these securities acquired
them for their own accounts. The certificates representing these securities will
bear a restricted  legend  providing that they cannot be sold except pursuant to
an effective registration statement or an exemption from registration.

Item 2.03.  Creation of a Direct Financial Obligation or an Obligation Under
            an Off-Balance Sheet Arrangement of a Registrant.

      See Item 1.01 of this report.

Item 3.02   Unregistered Sale of Equity Securities.

      See Item 1.01 of this report.
SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date: January 4, 2018.
                                AMERICANN, INC.

                                By:/s/ Benjamin J. Barton
                                   -------------------------------
                                   Benjamin J. Barton, Chief Financial Officer